Orphan Drug Act - PDFSEARCH.IO - Document Search Engine

Orphan Drug Act
Results: 190

#	Item
151	Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-06-10 11:16:34 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
152	OC - Budget[removed]Office of Orphan Products Development Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Pharmacology Pharmaceuticals policy Drug discovery Epidemiology Orphan drug Orphan Drug Act Federal Food Drug and Cosmetic Act Center for Devices and Radiological Health Food and Drug Administration Medicine Health
153	Federal Register / Vol. 78, No[removed]Wednesday, June 5, [removed]Notices • Identification of challenges, • Battery/device design and system integration, • Battery/device manufacturing process, Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2013-06-18 10:51:15 Clinical research Food and Drug Administration Health Therapeutics United States Public Health Service Prescription Drug User Fee Act Lung cancer Orphan drug Bevacizumab Pharmaceutical sciences Pharmaceuticals policy Pharmacology
154	Transcript: Public Workshop – Complex Issues in Developing Drug and Biological Products for Rare Diseases, January 6, 2014 Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Food and Drug Administration Drug discovery Pharmaceutical industry Pharmaceuticals policy Orphan drug Prescription Drug User Fee Act Rare disease FDA Fast Track Development Program Pharmaceutical sciences Health Medicine
155	[removed]Federal Register / Vol. 78, No[removed]Monday, September 23, [removed]Notices OMB Comment OMB is required to make a decision concerning the collection of information Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2013-09-21 03:26:13 Medicine Pharmaceutical sciences Orphan drug Prescription Drug User Fee Act FDA Fast Track Development Program Fibromyalgia Federal Food Drug and Cosmetic Act Norfloxacin Food and Drug Administration Amendments Act Health Food and Drug Administration Pharmaceuticals policy
156	Medical Devices for Rare Diseases: FDA/NIH Needs Assessment Project Gayatri R. Rao, M.D., J.D. Director Office of Orphan Products Development (OOPD) Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Food and Drug Administration Nursing research Epidemiology Drug discovery National Institutes of Health Rare disease Orphan Drug Act Orphan drug Medicine Health Research
157	Testimony of Marc Boutin, JD, Executive Vice President and Chief Operating Officer of the National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce June 9, 2014 Add to Reading List Source URL: docs.house.gov Language: English - Date: 2014-06-09 15:29:45 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
158	Testimony of Alexis Borisy Partner, Third Rock Ventures Before the U.S. House of Representatives Energy and Commerce Subcommittee on Health Hearing “21st Century Cures: Examining the Role of Incentives in Advancing Tre Add to Reading List Source URL: docs.house.gov Language: English - Date: 2014-06-09 15:29:18 Food and Drug Administration Drug discovery Pharmacy Pharmaceutical industry Clinical trial Orphan drug Prescription Drug User Fee Act FDA Fast Track Development Program Pharmaceutical drug Pharmaceutical sciences Pharmacology Health
159	Microsoft Word - hemphill testimony 10june14 11 am Add to Reading List Source URL: docs.house.gov Language: English - Date: 2014-06-10 12:10:04 Health Pharmaceutical industry Clinical pharmacology Drug discovery Generic drug Food and Drug Administration MODDERN Cures Act Orphan drug Abbreviated New Drug Application Pharmaceutical sciences Pharmaceuticals policy Pharmacology
160	Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-06-11 11:20:35 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research